Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Revenue projections:

Revenue projections for CLEAN
Revenue projections for CLEAN

With CLEAN's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio 0.000000
forwardPE 36.828087
debtToEquity 0.157000
earningsGrowth 0.049000
revenueGrowth 0.237000
grossMargins 0.540890
operatingMargins 0.332890
trailingEps 24.580000
forwardEps 35.090000

CLEAN's positive gross and operating margins suggest that the company is operating profitably. These strong margins indicate effective cost management and revenue generation, contributing to a solid financial foundation.
CLEAN's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that CLEAN is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

Price projections for CLEAN
Price projections for CLEAN

Clean Science and Technology Limited's price has continuously remained near the lower end of analysts' projections, indicating that it may be facing challenges in meeting market expectations. This trend raises concerns about the company's future growth trajectory.

Insider Transactions:

Insider Transactions for CLEAN
Insider Transactions for CLEAN


CLEAN stock was sold in 3 transactions, with market price at 1363.9333089192708.There were no sell transactions during the period under consideration.CLEAN's current price levels are experiencing more buying activity than selling, which may point to a favorable outlook. This trend suggests investor confidence in the stock's future, potentially indicating expectations of continued growth.

Recommendation changes over time:

Recommendations trend for CLEAN
Recommendations trend for CLEAN


Analysts' buy bias for CLEAN signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to CLEAN, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.